9 / 83
P
olycystic
ovary
syndrome
:
controversies
and
challenges
R
ev
A
ssoc
M
ed
B
ras
2015; 61(6):485-487
487
18. Liu W, Dong S, Li Y, Shi L, Zhou W, Liu Y et al. Randomized controlled trial
comparing letrozole with laparoscopic ovarian drilling in women with
clomiphene citrate-resistant polycystic ovary syndrome. Exp Ther Med. 2015;
10(4):1297-1302.
19. Iwata MC, Porquere L, Sorpreso IC, Baracat EC, Soares JM Jr. Association of oral
contraceptive and metformin did not improve insulin resistance in women with
polycystic ovary syndrome. Rev Assoc Med Bras. 2015; 61(3):215-9.
20. Nakano K, Ando H, Kurokawa S, Hosohata K, Ushijima K, Takada M et al.
Association of decreased mRNA expression of multidrug and toxin extrusion
protein 1 in peripheral blood cells with the development of flutamide-induced
liver injury. Cancer Chemother Pharmacol. 2015; 75(6):1191-7.
21. Maciel GA, Soares JM Jr, Alves da Motta EL, Abi Haidar M, de Lima GR, Baracat
EC. Nonobese women with polycystic ovary syndrome respond better than
obese women to treatment with metformin. Fertil Steril. 2004; 81(2):355-60.
22. Jensterle M, Pirš B, Goričar K, Dolžan V, Janež A. Genetic variability in GLP-
1 receptor is associated with inter-individual differences in weight lowering
potential of liraglutide in obese women with PCOS: a pilot study. Eur J Clin
Pharmacol. 2015; 71(7):817-24.